D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
KPTI holding history
Karyopharm Therapeutics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KPTI overviewAll 13F holders of KPTIFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −15,312−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q4 2024 | 229,685 | $155.3K | <0.1% | −817,711−78.1% | Reduced | Holders |
| Q3 2024 | 1,047,396 | $869.3K | <0.1% | +203,284+24.1% | Added | Holders |
| Q2 2024 | 844,112 | $732.4K | <0.1% | −118,713−12.3% | Reduced | Holders |
| Q1 2024 | 962,825 | $1.45M | <0.1% | +345,609+56.0% | Added | Holders |
| Q4 2023 | 617,216 | $533.9K | <0.1% | −5,639−0.9% | Reduced | Holders |
| Q3 2023 | 622,855 | $834.6K | <0.1% | +25,096+4.2% | Added | Holders |
| Q2 2023 | 597,759 | $1.07M | <0.1% | +48,152+8.8% | Added | Holders |
| Q1 2023 | 549,607 | $2.14M | <0.1% | +241,648+78.5% | Added | Holders |
| Q4 2022 | 307,959 | $1.05M | <0.1% | +164,153+114.1% | Added | Holders |
| Q3 2022 | 143,806 | $785.0K | <0.1% | +85,306+145.8% | Added | Holders |
| Q2 2022 | 58,500 | $264.0K | <0.1% | +24,387+71.5% | Added | Holders |
| Q1 2022 | 34,113 | $251.0K | <0.1% | −141,938−80.6% | Reduced | Holders |
| Q4 2021 | 176,051 | $1.13M | <0.1% | +176,051 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −14,865−100.0% | Sold out | Holders |
| Q1 2021 | 14,865 | $156.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.